Immunic, Inc. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Immunic, Inc. stock issued during period, value, new issues for the quarter ending 2022-06-30 was $130.00K.
- Immunic, Inc. stock issued during period, value, new issues for the quarter ending 2022-03-31 was $5.00K, a 99.94% decline year-over-year.
- Immunic, Inc. stock issued during period, value, new issues for the quarter ending 2021-03-31 was $8.63M, a 1418.49% increase year-over-year.
- Immunic, Inc. stock issued during period, value, new issues for the quarter ending 2020-03-31 was $568.00K.
- Immunic, Inc. stock issued during period, value, new issues for fiscal 2022 was $5.00K.
- Immunic, Inc. stock issued during period, value, new issues for fiscal 2019 was $0.00.
- Immunic, Inc. stock issued during period, value, new issues for fiscal 2018 was $0.00, a 100.00% decline from fiscal 2017.
- Immunic, Inc. stock issued during period, value, new issues for fiscal 2017 was $37.94M, a 207.08% increase from fiscal 2016.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2022-12-31 | $5.00K 10-K · filed 2023-02-23 | |
| 2022-06-30 | $130.00K 10-Q · filed 2022-11-03 | |
| 2022-03-31 | $5.00K 10-Q · filed 2023-11-14 | |
| 2021-03-31 | $8.63M 10-Q · filed 2021-11-04 | |
| 2020-03-31 | $568.00K 10-Q · filed 2021-11-04 | |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $0.00 10-K · filed 2021-02-26 |
| 2019-09-30 | $0.00 10-Q · filed 2020-11-06 | |
| 2018-12-31 | $0.00 10-K · filed 2020-03-16 | |
| 2017-12-31 | $37.94M 10-K · filed 2019-03-04 | |
| 2016-12-31 | $12.36M 10-K · filed 2019-03-04 | |
| 2016-06-30 | $4.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-02 | |
| 2016-03-31 | $4.50M 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $32.15M 10-K · filed 2018-03-13 | |
| 2014-12-31 | $32.85M 10-K · filed 2017-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B |